These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7662572)

  • 21. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acanthosis nigricans: clinical predictor of abnormal glucose tolerance in Asian women with polycystic ovary syndrome.
    Charnvises K; Weerakiet S; Tingthanatikul Y; Wansumrith S; Chanprasertyothin S; Rojanasakul A
    Gynecol Endocrinol; 2005 Sep; 21(3):161-4. PubMed ID: 16335908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired glucose tolerance in patients with polycystic ovary syndrome (PCOS).
    Kinoshita T; Kato J
    Horm Res; 1990; 33 Suppl 2():18-20. PubMed ID: 2095356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acromegaly with polycystic ovaries, hyperandrogenism, hirsutism, insulin resistance and acanthosis nigricans: a case report.
    Unal A; Sahin Y; Keleştimur F
    Endocr J; 1993 Apr; 40(2):207-11. PubMed ID: 7951506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of acanthosis nigricans in childhood obesity.
    Guran T; Turan S; Akcay T; Bereket A
    J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glucose and lipid metabolism in patients with polycystic ovary syndrome].
    Ge XL; Lou SZ; Shen HM
    Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):527-30, 573. PubMed ID: 7835128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents.
    Silfen ME; Denburg MR; Manibo AM; Lobo RA; Jaffe R; Ferin M; Levine LS; Oberfield SE
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4682-8. PubMed ID: 14557441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship among obesity, insulin resistance, and hyperinsulinemia in the polycystic ovary syndrome.
    Dahan MH; Reaven G
    Endocrine; 2019 Jun; 64(3):685-689. PubMed ID: 30900204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucose intolerance in Japanese patients with polycystic ovary syndrome.
    Kurioka H; Takahashi K; Miyazaki K
    Arch Gynecol Obstet; 2007 Mar; 275(3):169-73. PubMed ID: 16972071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
    Souza Dos Santos AC; Soares NP; Costa EC; de Sá JC; Azevedo GD; Lemos TM
    Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin resistance, acanthosis nigricans, and polycystic ovaries associated with a circulating inhibitor of postbinding insulin action.
    Harrison LC; Dean B; Peluso I; Clark S; Ward G
    J Clin Endocrinol Metab; 1985 May; 60(5):1047-52. PubMed ID: 3884647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leptin concentrations in hirsute women with polycystic ovary syndrome or idiopathic hirsutism: influence on LH and relationship with hormonal, metabolic, and anthropometric measurements.
    Spritzer PM; Poy M; Wiltgen D; Mylius LS; Capp E
    Hum Reprod; 2001 Jul; 16(7):1340-6. PubMed ID: 11425810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
    Ardawi MS; Rouzi AA
    Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperandrogenism, Insulin Resistance, and Acanthosis Nigricans (HAIR-AN) Syndrome Reflects Adipose Tissue Dysfunction ("Adiposopathy" or "Sick Fat") in Asian Indian Girls.
    Agrawal K; Mathur R; Purwar N; Mathur SK; Mathur DK
    Dermatology; 2021; 237(5):797-805. PubMed ID: 33445175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum insulin patterns and the relationship between insulin sensitivity and glycaemic profile in women with polycystic ovary syndrome.
    Seneviratne HR; Lankeshwara D; Wijeratne S; Somasunderam N; Athukorale D
    BJOG; 2009 Dec; 116(13):1722-8. PubMed ID: 19775306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
    Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
    Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proinsulin serum concentrations in women with polycystic ovary syndrome: a marker of beta-cell dysfunction?
    Maliqueo M; Atwater I; Lahsen R; Pérez-Bravo F; Angel B; Sir-Petermann T
    Hum Reprod; 2003 Dec; 18(12):2683-8. PubMed ID: 14645192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens.
    Sepilian VP; Crochet JR; Nagamani M
    Fertil Steril; 2006 May; 85(5):1441-7. PubMed ID: 16579998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma visfatin level in women with polycystic ovary syndrome.
    Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
    Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galectin-3 is a potential biomarker to insulin resistance and obesity in women with polycystic ovary syndrome.
    Alves MT; de Souza IDP; Ferreira CN; Cândido AL; Bizzi MF; Oliveira FR; Reis FM; Gomes KB
    Gynecol Endocrinol; 2020 Sep; 36(9):760-763. PubMed ID: 32157924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.